user

Impact of Directly Acting Antivirals (DAAs) Treatment on Rates of Hepatocellular Carcinoma (HCC) in Hepatitis C Virus (HCV) and HIV Co-infected Patients

被引：0
|
作者：
Bari, Shahla [1 ]
Chan, Austin [1 ]
Olanipekun, Titilope [1 ]
Chawla, Saurabh [2 ]
机构：
[1] Morehouse Sch Med, Atlanta, GA 30310 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
888
引用
收藏
页码：S493 / S494
页数：2
相关论文
共 50 条
  • [1] Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
    Carrasco, Itziar
    Sainz, Talia
    Antoinette Frick, Marie
    Jimenez de Ory, Santiago
    Fortuny, Claudia
    Burgos, Joaquin
    Montero, Marta
    Gavilan, Cesar
    Dolores Falcon, Maria
    Antonio Couceiro, Jose
    Ignacio Bernardino, Jose
    Bisbal, Otilia
    Guerrero, Carmelo
    Teresa Aldamiz-Echevarria, Maria
    Berenguer, Juan
    Luisa Navarro, Maria
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 955 - 958
  • [2] Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals
    Hasson, Hamid
    Merli, Marco
    Messina, Emanuela
    Bhoori, Sherrie
    Salpietro, Stefania
    Morsica, Giulia
    Regalia, Enrico
    Bagaglio, Sabrina
    Lazzarin, Adriano
    Uberti-Foppa, Caterina
    Mazzaferro, Vincenzo
    JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 415 - 417
  • [3] Effect of treatment of hepatitis C by directly acting antivirals on chronic hepatitis C and B co-infected patients
    Ahmed, Afify
    Elantouny, Neveen
    Zidan, Amal
    Sadek, Ayman
    Elrasad, Mohamed
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E726 - E726
  • [4] Antiviral Treatment for Hepatitis C Virus in HIV/HCV Co-infected Patients
    Ioannou, George N.
    Scott, John D.
    Yang, Yin
    Green, Pamela
    Beste, Lauren A.
    HEPATOLOGY, 2013, 58 : 225A - 225A
  • [5] Directly acting antivirals for hepatitis C virus arrive in HIV/hepatitis C virus co-infected patients: from 'mind the gap' to 'where's the gap?'
    Childs, Kate
    Taylor, Chris
    Dieterich, Douglas
    Agarwal, Kosh
    AIDS, 2016, 30 (07) : 975 - 989
  • [6] Lack of compliance to hepatocellular carcinoma (HCC) screening guidelines in hepatitis B (HBV) or C (HCV) virus co-infected HIV patients with cirrhosis
    Willemse, Sophie
    HEPATOLOGY, 2016, 64 : 870A - 870A
  • [7] Liver fibrosis evolution after hepatitis C treatment with direct acting antivirals (DAA) in co-infected patients HCV/HIV
    Mendez, J.
    Videira Santos, F.
    Cipriano, A.
    Soeiro, C.
    Valdoleiros, S.
    Goncalves, C.
    Tavares, A. P.
    Castro, R. Sarmento E.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 241 - 241
  • [8] Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
    Mohamed, Inas E. L-Khedr
    EL-Saeed, Kadry Mohamed
    Al-Sadik, Mahmoud Hassan
    Anwar, Christina Alphonse
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [9] Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
    Inas E L-Khedr Mohamed
    Kadry Mohamed EL-Saeed
    Mahmoud Hassan Al-Sadik
    Christina Alphonse Anwar
    Egyptian Liver Journal, 11
  • [10] Risk of hepatocellular carcinoma (HCC) recurrence in HCV cirrhotic patients treated with Direct Acting Antivirals (DAAs)
    Cabibbo, G.
    Cacciola, I.
    Cannavo, M. R.
    Madonia, S.
    Calvaruso, V.
    Petta, S.
    Distefano, M.
    Larocca, L.
    Prestileo, T.
    Tine, F.
    Digiacomo, A.
    Bertino, G.
    Giannitrapani, L.
    Benanti, F.
    Davi, A.
    Volpes, R.
    Scalisi, I.
    Iacobello, C.
    Mazzola, G.
    Cartabellotta, F.
    Guarneri, L.
    Portelli, V.
    Averna, A.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    Camma, C.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 (01) : E59 - E59
12345